There are 2934 resources available
How could targeted therapies influence the management landscape?
Presenter: Yohann Loriot
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Can the molecular biology knowledge be integrated into the clinical practice today?
Presenter: Arlene Siefker-Radtke
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Advanced urothelial carcinoma 2.0: Are we ready for a paradigm shift? Closing remarks
Presenter: Maria De Santis
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Introduction: Welcome to the future?
Presenter: Joaquim Bellmunt
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
The path to now: How did the current management of advanced urothelial carcinoma develop?
Presenter: Shahrokh F. Shariat
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
What is today’s understanding of the molecular landscape of advanced urothelial carcinoma?
Presenter: Eva Comperat
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Role of imaging follow-up
Presenter: Virginie Westeel
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Role of patient reported outcome in patients' follow-up
Presenter: Paul van Schil
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Patient perspective/expectations
Presenter: Regine Ihlen
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Thierry Berghmans
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Webcast